Ultralife (ULBI) Scheduled to Post Earnings on Thursday

Ultralife (NASDAQ:ULBI) is scheduled to release its earnings data before the market opens on Thursday, April 25th. Persons interested in registering for the company’s earnings conference call can do so using this link.

Ultralife (NASDAQ:ULBI) last issued its earnings results on Thursday, February 15th. The technology company reported $0.18 EPS for the quarter. The company had revenue of $44.55 million during the quarter. Ultralife had a net margin of 4.54% and a return on equity of 7.36%.

Ultralife Stock Performance

Shares of Ultralife stock opened at $8.78 on Thursday. The firm has a fifty day moving average of $9.02 and a two-hundred day moving average of $8.25. The stock has a market capitalization of $144.43 million, a price-to-earnings ratio of 19.95 and a beta of 1.26. Ultralife has a 52 week low of $3.92 and a 52 week high of $11.85. The company has a debt-to-equity ratio of 0.19, a quick ratio of 2.02 and a current ratio of 3.80.

Hedge Funds Weigh In On Ultralife

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ULBI. Dimensional Fund Advisors LP lifted its position in Ultralife by 3.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 931,030 shares of the technology company’s stock worth $6,350,000 after buying an additional 31,194 shares in the last quarter. Vanguard Group Inc. lifted its position in Ultralife by 8.1% during the 3rd quarter. Vanguard Group Inc. now owns 509,200 shares of the technology company’s stock worth $4,970,000 after buying an additional 38,309 shares in the last quarter. Renaissance Technologies LLC lifted its position in Ultralife by 9.6% during the 2nd quarter. Renaissance Technologies LLC now owns 193,690 shares of the technology company’s stock worth $937,000 after buying an additional 17,000 shares in the last quarter. BlackRock Inc. lifted its position in Ultralife by 2.0% during the 2nd quarter. BlackRock Inc. now owns 145,230 shares of the technology company’s stock worth $703,000 after buying an additional 2,873 shares in the last quarter. Finally, State Street Corp lifted its position in Ultralife by 6.9% during the 1st quarter. State Street Corp now owns 40,120 shares of the technology company’s stock worth $215,000 after buying an additional 2,596 shares in the last quarter. 30.68% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

ULBI has been the subject of several research analyst reports. Benchmark boosted their price target on shares of Ultralife from $12.00 to $13.00 and gave the company a “buy” rating in a report on Tuesday, March 5th. StockNews.com lowered shares of Ultralife from a “strong-buy” rating to a “buy” rating in a report on Tuesday, March 26th.

Ultralife Company Profile

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.